These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 27697643)

  • 1. Berberine and inflammatory bowel disease: A concise review.
    Habtemariam S
    Pharmacol Res; 2016 Nov; 113(Pt A):592-599. PubMed ID: 27697643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tracking evidences of Coptis chinensis for the treatment of inflammatory bowel disease from pharmacological, pharmacokinetic to clinical studies.
    Yang Y; Vong CT; Zeng S; Gao C; Chen Z; Fu C; Wang S; Zou L; Wang A; Wang Y
    J Ethnopharmacol; 2021 Mar; 268():113573. PubMed ID: 33181286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Berberine pharmacology and the gut microbiota: A hidden therapeutic link.
    Habtemariam S
    Pharmacol Res; 2020 May; 155():104722. PubMed ID: 32105754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine.
    Imanshahidi M; Hosseinzadeh H
    Phytother Res; 2008 Aug; 22(8):999-1012. PubMed ID: 18618524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berberine and neurodegeneration: A review of literature.
    Ahmed T; Gilani AU; Abdollahi M; Daglia M; Nabavi SF; Nabavi SM
    Pharmacol Rep; 2015 Oct; 67(5):970-9. PubMed ID: 26398393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of anti-inflammatory and anti-angiogenic activity of berberine by novel rapid dissolving nanoemulsifying technique.
    Pund S; Borade G; Rasve G
    Phytomedicine; 2014 Feb; 21(3):307-14. PubMed ID: 24176841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Berberine ameliorates intestinal mucosal barrier damage induced by peritoneal air exposure.
    Tan S; Yu W; Lin Z; Chen Q; Shi J; Dong Y; Duan K; Bai X; Xu L; Yu Z; Li J; Li N
    Biol Pharm Bull; 2015; 38(1):122-6. PubMed ID: 25341882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Berberine and Its Role in Chronic Disease.
    Cicero AF; Baggioni A
    Adv Exp Med Biol; 2016; 928():27-45. PubMed ID: 27671811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of berberine in the gastrointestinal tract - a review of actions and therapeutic implications.
    Chen C; Yu Z; Li Y; Fichna J; Storr M
    Am J Chin Med; 2014; 42(5):1053-70. PubMed ID: 25183302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory, antioxidant, and immunomodulatory effects of Berberis vulgaris and its constituent berberine, experimental and clinical, a review.
    Shakeri F; Kiani S; Rahimi G; Boskabady MH
    Phytother Res; 2024 Apr; 38(4):1882-1902. PubMed ID: 38358731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberine.
    Altern Med Rev; 2000 Apr; 5(2):175-7. PubMed ID: 10767672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Berberine: Is it a Promising Agent for Mental Disorders Treatment?
    Shayganfard M
    Curr Mol Pharmacol; 2023; 16(3):307-320. PubMed ID: 35538795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic options to modulate barrier defects in inflammatory bowel disease.
    Hering NA; Schulzke JD
    Dig Dis; 2009; 27(4):450-4. PubMed ID: 19897959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Berberine Administration in Treatment of Colitis: A Review.
    Ashrafizadeh M; Najafi M; Mohammadinejad R; Farkhondeh T; Samarghandian S
    Curr Drug Targets; 2020; 21(13):1385-1393. PubMed ID: 32564751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine and its derivatives represent as the promising therapeutic agents for inflammatory disorders.
    Lu Q; Fu Y; Li H
    Pharmacol Rep; 2022 Apr; 74(2):297-309. PubMed ID: 35083737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demethyleneberberine alleviates inflammatory bowel disease in mice through regulating NF-κB signaling and T-helper cell homeostasis.
    Chen YY; Li RY; Shi MJ; Zhao YX; Yan Y; Xu XX; Zhang M; Zhao XT; Zhang YB
    Inflamm Res; 2017 Feb; 66(2):187-196. PubMed ID: 27900412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advance of studies on anti-atherosclerosis mechanism of berberine.
    Wu M; Wang J; Liu LT
    Chin J Integr Med; 2010 Apr; 16(2):188-92. PubMed ID: 20473748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of turmeric on colon histology, body weight, ulcer, IL-23, MPO and glutathione in acetic-acid-induced inflammatory bowel disease in rats.
    Bastaki SMA; Al Ahmed MM; Al Zaabi A; Amir N; Adeghate E
    BMC Complement Altern Med; 2016 Feb; 16():72. PubMed ID: 26907175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Berberine for bone regeneration: Therapeutic potential and molecular mechanisms.
    Zhang Y; Ma J; Zhang W
    J Ethnopharmacol; 2021 Sep; 277():114249. PubMed ID: 34058315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin as a therapeutic agent in the chemoprevention of inflammatory bowel disease.
    Sreedhar R; Arumugam S; Thandavarayan RA; Karuppagounder V; Watanabe K
    Drug Discov Today; 2016 May; 21(5):843-9. PubMed ID: 26995272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.